AAPL 167.04 -0.5714% MSFT 404.33 -1.8235% GOOG 157.46 0.3697% GOOGL 155.9725 0.3232% AMZN 179.17 -1.1639% NVDA 846.71 0.7568% META 501.8 1.544% TSLA 149.9 -3.5703% TSM 132.27 -4.8623% LLY 745.95 -0.642% V 271.36 -0.4877% AVGO 1258.99 -1.8431% JPM 181.25 0.6497% UNH 493.18 2.9625% NVO 122.75 -1.4294% WMT 59.27 -0.637% LVMUY 170.18 -0.3338% XOM 118.47 -0.1349% LVMHF 854.0 -0.4662% MA 454.7 -1.1865%
Cognex Corporation
CGNX Details
Cognex Corporation (NASDAQ: CGNX) is a leading worldwide provider of machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks where vision is required. Machine vision is the technology that gives computers and automation equipment the ability to see. Machine vision products are used to automate the manufacturing and tracking of discrete items, such as mobile phones, aspirin bottles, and automobile tires, by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process
Latest News:
Q1FY22 Results:
Key Risks:
A significant portion of the company’s products is presently manufactured by a third-party contractor located in Indonesia. Further, certain key electronic and mechanical components, such as integrated circuit chips, are fundamental to the design of Cognex products. Due to the impact of the COVID-19 pandemic and other factors, CGNX has experienced, and may continue to experience, disruptions to the supply of components for the company’s products that have resulted, and may continue to result, in higher purchase costs, delivery costs, and manufacturing delays.
Outlook:
Valuation Methodology: Price/Earnings Per Share Multiple Based Relative Valuation
(Analysis by Kalkine Group)
* % Premium/(Discount) is based on our assessment of the company's FY1 trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation:
Cognex Corporation has built upon strong fundamentals, strong competitive advantage against the peers from the margin standpoint, business protected through patents and IP rights. The company has track record of 19-year of consecutive payment of dividend, returned USD 1.5 billion of total cash to shareholders since 1981, recorded 14% 10-year revenue CAGR (2011-2021), and invest heavily in R&D to enhance the value proposition of its products, with 13% revenue deployed inti R&D in 2021.
Further, CGNX shares have corrected significantly over the past three months, down ~35% in the same time and mostly tilted towards its 52W Low (52W range (H/L)- USD 92.17/USD 45.66).
Given the recent correction in the stock and from the valuation standpoint, CGNX shares looks attractive at the current trading levels. Hence, we recommend a "Buy" rating on the stock at the closing price of USD 49.07, down ~2% as of May 16, 2022, at 11:08 AM PDT.
1-Year Technical Price Chart (May 16, 2022, at 11:08 AM PDT). Source: REFINITIV, Analysis by Kalkine Group
Technical Levels Summary
Technical Indicators Defined: -
Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decision should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the Valuation has been achieved and subject to the factors discussed above.
Note 3: The report publishing date is as per the Pacific Time Zone.